NO901213L - GENETIC DEVICES FOR INHIBITING THE RNA FUNCTION. - Google Patents

GENETIC DEVICES FOR INHIBITING THE RNA FUNCTION.

Info

Publication number
NO901213L
NO901213L NO90901213A NO901213A NO901213L NO 901213 L NO901213 L NO 901213L NO 90901213 A NO90901213 A NO 90901213A NO 901213 A NO901213 A NO 901213A NO 901213 L NO901213 L NO 901213L
Authority
NO
Norway
Prior art keywords
units
rna
inhibiting
genetic
unit
Prior art date
Application number
NO90901213A
Other languages
Norwegian (no)
Other versions
NO901213D0 (en
NO306623B1 (en
Inventor
Hartmut Beug
Max L Birnstiel
Matthew Cotten
Ernst Wagner
Harald Kandolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO901213D0 publication Critical patent/NO901213D0/en
Publication of NO901213L publication Critical patent/NO901213L/en
Publication of NO306623B1 publication Critical patent/NO306623B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a genetic unit, which is optionally in multicopy form, for the inhibition of RNA. The unit contains the transcription units necessary for transcription by polymerase III, and a DNA which codes for inhibiting RNA and which is arranged within the unit in such a way that the transcribed RNA is part of the polymerase III transcript. These units can be used to achieve increased stability of the inhibiting RNA, which can be in the form of ribozymes or antisense RNAs, while there is no reduction in the activity. The invention furthermore relates to a process for introducing the genetic units into the cell, to the use of these units and to pharmaceutical formulations containing them.
NO901213A 1989-03-16 1990-03-15 Method of Preparation of DNA Molecule Containing Parts of a Gene Transcribed by Polymerase III and a DNA Sequence Encoding an Inhibitory RNA Molecule NO306623B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (3)

Publication Number Publication Date
NO901213D0 NO901213D0 (en) 1990-03-15
NO901213L true NO901213L (en) 1990-09-17
NO306623B1 NO306623B1 (en) 1999-11-29

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901213A NO306623B1 (en) 1989-03-16 1990-03-15 Method of Preparation of DNA Molecule Containing Parts of a Gene Transcribed by Polymerase III and a DNA Sequence Encoding an Inhibitory RNA Molecule

Country Status (20)

Country Link
EP (1) EP0387775B1 (en)
JP (1) JP3330930B2 (en)
KR (1) KR900014591A (en)
AT (1) ATE140961T1 (en)
AU (1) AU637354B2 (en)
CA (1) CA2012312C (en)
DD (1) DD297838A5 (en)
DE (1) DE59010432D1 (en)
DK (1) DK0387775T3 (en)
ES (1) ES2090049T3 (en)
FI (1) FI105103B (en)
GR (1) GR3020935T3 (en)
HU (2) HU215187B (en)
IE (1) IE74850B1 (en)
IL (1) IL93754A (en)
NO (1) NO306623B1 (en)
NZ (1) NZ232917A (en)
PT (1) PT93440B (en)
RU (1) RU2136751C1 (en)
ZA (1) ZA901973B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04505261A (en) * 1989-05-10 1992-09-17 スローン―ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ Stably transformed eukaryotic cells containing transcribable foreign DNA under the control of a Pol III promoter
DE4091533T (en) * 1989-08-31 1992-01-30
JP2507895B2 (en) * 1989-12-19 1996-06-19 工業技術院長 New synthesis system of ribozyme
WO1991019789A1 (en) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
ATE147098T1 (en) * 1990-10-12 1997-01-15 Max Planck Gesellschaft MODIFIED RIBOZYMES
DE4104186A1 (en) * 1991-02-12 1992-08-13 Genentech Inc NEW COMPLEXES INCLUDING ENDOCYTOSIS IN HIGHER EUKARYOTIC CELLS, NUCLEIC ACID
FR2687411A1 (en) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vector comprising a viral gene transcribed by RNA polymerase III, and process for the intercellular production of RNA
AU4259193A (en) * 1992-04-28 1993-11-29 Frank Andreas Harald Meyer Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
WO1993023057A1 (en) * 1992-05-14 1993-11-25 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting cancer development
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
CA2114312A1 (en) * 1992-05-27 1993-12-09 John J. Rossi Chimeric trnalys-ribozyme molecules
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
EP0652705B1 (en) * 1992-06-29 2005-12-14 Gene Shears Pty Limited Nucleic acids and methods of use thereof for controlling viral pathogens
WO1994013798A1 (en) * 1992-12-16 1994-06-23 Bergmann Johanna E Agents for the prevention and treatment of human alzheimer's disease
DE69333216T2 (en) * 1993-07-06 2004-06-24 Université de Nice-Sophia Antipolis Vector, contains a virus gene transcribed in ARN polymerase III
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
AU692208B2 (en) * 1994-01-24 1998-06-04 City Of Hope Inhibitors and target molecule co-localization
DE4424761C1 (en) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expression cassette for continuous, stable prodn. of ribozyme
EP0837933A4 (en) 1995-06-07 2003-05-21 Commw Scient Ind Res Org Optimized minizymes and miniribozymes and uses thereof
FR2755976B1 (en) * 1996-11-15 1999-01-15 Idm Immuno Designed Molecules NOVEL COMPLEXES OF NUCLEIC ACIDS AND POLYMER SUBSTITUTED BY RESIDUES CAUSING THE DESTABILIZATION OF CELL MEMBRANES
US6057156A (en) * 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
AU1187099A (en) * 1997-10-21 1999-05-10 Ribozyme Pharmaceuticals, Inc. Peptide bond formation using nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
ES2374290T3 (en) 1998-03-20 2012-02-15 Commonwealth Scientific And Industrial Research Organisation SYNTHETIC GENES AND GENETIC CONSTRUCTS THAT INCLUDE THE SAME.
CA2361201A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
JP3330930B2 (en) 2002-10-07
KR900014591A (en) 1990-10-24
HUT54206A (en) 1991-01-28
IE74850B1 (en) 1997-08-13
IL93754A (en) 1995-12-31
HU901584D0 (en) 1990-06-28
EP0387775B1 (en) 1996-07-31
PT93440B (en) 2001-07-31
IL93754A0 (en) 1990-12-23
HU211868A9 (en) 1995-12-28
PT93440A (en) 1990-11-07
CA2012312C (en) 2001-08-14
HU215187B (en) 1998-10-28
ES2090049T3 (en) 1996-10-16
ZA901973B (en) 1991-11-27
JPH03130080A (en) 1991-06-03
GR3020935T3 (en) 1996-12-31
AU637354B2 (en) 1993-05-27
CA2012312A1 (en) 1990-09-16
ATE140961T1 (en) 1996-08-15
FI105103B (en) 2000-06-15
RU2136751C1 (en) 1999-09-10
AU5130190A (en) 1990-11-01
IE900931L (en) 1990-09-16
DE59010432D1 (en) 1996-09-05
NZ232917A (en) 1997-07-27
DK0387775T3 (en) 1996-11-04
EP0387775A1 (en) 1990-09-19
NO901213D0 (en) 1990-03-15
DD297838A5 (en) 1992-01-23
FI901296A0 (en) 1990-03-15
NO306623B1 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
NO901213L (en) GENETIC DEVICES FOR INHIBITING THE RNA FUNCTION.
WO1996019568A3 (en) Stabilized ribozyme analogs
PT731835E (en) OLIGONUCLEOTIDOS ANTI-SENSE POSSESSING ACTIVITY INHIBITOR OF TUMORIGENICITY
AU4072089A (en) Inhibition of htlv-iii by exogenous oligonucleotides
ATE189264T1 (en) CHIMERIC OLIGONUCLEOTIDE AND USE THEREOF FOR PRODUCING NUCLEIC ACID TRANSCRIPTS
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
EP0572287A3 (en) Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression
EP0637316A4 (en) Antisense oligonucleotide inhibition of papillomavirus.
ATE217904T1 (en) NUCLEOZYMES
HUP0103465A2 (en) Short oligonucleotides for the inhibition of vegf expression
EP0708829B8 (en) A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
HUP9702377A2 (en) Self-enhancing, pharmacologically controllable expression systems
Nakashima et al. Proximity of mRNA5′-region and 18S rRNA in eukaryotic initiation complexes
DK1175489T3 (en) Oligonucleotides containing an antisense sequence stabilized by a secondary structure and pharmaceutical preparations containing these oligonucleotides
DE69921609D1 (en) RIBOCYMAL NUCLEIC ACID CUTTING THE CCR5 OR CXCR4
Hatta et al. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides
AU6144294A (en) Plant virus resistance conferring polyribozyme and resistant plants producing same
Richardson et al. Identification of upstream sequence components of rho-dependent transcription terminators.
AU3956100A (en) Rna polymerase i transcription factor tif-ia
UA19318A (en) Method for human mno2-dismutase obtaining
Cho The Regulation of Bacteriophage N4 Transcription

Legal Events

Date Code Title Description
MK1K Patent expired